1,500
Participants
Start Date
October 31, 2016
Primary Completion Date
January 23, 2025
Study Completion Date
January 23, 2025
NYU Langone Health, New York
Weill Cornell Medical College, New York
Columbia University Medical Center, New York
Sandra Atlas Bass Center for Liver Diseases, Manhasset
University of Pennsylvania, Philadelphia
Mercy Medical Center, GI Research, Baltimore
Bon Secours Liver Institute of Virginia, Richmond
Virginia Commonwealth University (VCU), Richmond
University of North Carolina at Chapel Hill, Chapel Hill
Duke University Medical Center, Durham
Center for Liver Disease and Transplant at CMC, Charlotte
Piedmont Atlanta Hospital, Atlanta
University of Florida Hepatology Research, Gainesville
SCFLD/University of Miami, Miami
Gastro Florida, Clearwater
Southern Therapy and Advanced Research LLC (STAR), Jackson
Ohio State University Medical Center, Columbus
University of Michigan, Ann Arbor
University of Iowa, Iowa City
University of Wisconsin, Madison
Illinois Gastroenterology Group, Arlington Heights
Rush University Medical Center, Chicago
University of Chicago, Chicago
Saint Louis University, St Louis
University of Nebraska, Omaha
University of Arkansas, Little Rock
UT Southwestern Medical Center, Dallas
Liver Associates of Texas, P.A., Houston
Pinnacle Clinical Research, Live Oak
University of Colorado- Anschutz Medical Campus, Aurora
Banner University Medical Center, Phoenix
Mayo Clinic, Phoenix
Institute for Liver Health, Chandler
California Liver Research Institute, Pasadena
Stanford University Medical Center, Palo Alto
University of California Davis, Sacramento
University of Washington, Seattle
Yale Internal Medicine, Digestive Diseases, New Haven
Baylor,Scott and White All Saints, Fort Worth
Target PharmaSolutions, Inc.
INDUSTRY